Cover Image

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection

Li-Juan Zhi,1,2,* Li Wang,2,3,* Xing-Kai Chen,4 Xiao-Ying Zhai,3 Li Wen,3 Lei Dong,1,2 Evelyne Jacqz-Aigrain,5,6 Zhong-Ren Shi,2,* Wei Zhao1,2,4,* 1Department of Pharmacy, Children’s Hospital of Hebei Province, Shijiazhuang, People’s Republic of China; 2Pediatric Research Institu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhi LJ (Author), Wang L (Author), Chen XK (Author), Zhai XY (Author), Wen L (Author), Dong L (Author), Jacqz-Aigrain E (Author), Shi ZR (Author), Zhao W (Author)
Format:	Book
Published:	Dove Medical Press, 2018-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
by: Bin Du, et al.
Published: (2021)

Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review
by: Stéphanie Leroux, et al.
Published: (2021)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
by: Sixuan Zhao, et al.
Published: (2021)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
by: Tao Zhang, et al.
Published: (2020)

Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
by: Yang Zhao, et al.
Published: (2020)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
by: Wen-Qian Fu, et al.
Published: (2022)

Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases
by: Buddharat Khan-asa, et al.
Published: (2020)

Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis
by: S. D'Agate, et al.
Published: (2021)

Population pharmacokinetics and dose optimization of magnesium sulfate in Chinese preeclampsia population
by: Jing Deng, et al.
Published: (2024)

Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
by: Danhong Liang, et al.
Published: (2023)

Population Pharmacokinetic Models of Venetoclax in Hematologic Malignancies: A Systematic Review
by: Zhao Y, et al.
Published: (2024)

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
by: SiChan Li, et al.
Published: (2021)

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
by: Mengting Li, et al.
Published: (2024)

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
by: Yang Wang, et al.
Published: (2022)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
by: Chao‐Yang Chen, et al.
Published: (2023)

Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations
by: Yuan J, et al.
Published: (2021)

Population pharmacokinetics, dosing optimization and clinical outcomes of biapenem in patients with sepsis
by: Dayu Chen, et al.
Published: (2024)

Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
by: Beate Aurich, et al.
Published: (2021)

Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
by: Xiping Li, et al.
Published: (2024)

Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and <i>P. aeruginosa</i>
by: Pier Giorgio Cojutti, et al.
Published: (2020)

Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation
by: Xiao Chen, et al.
Published: (2022)

Phenobarbital Pharmacokinetics and Optimal Dosing of Phenobarbital
by: Safiullah Shareef, et al.
Published: (2018)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
by: Hao Liang, et al.
Published: (2024)

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
by: Eliška Dvořáčková, et al.
Published: (2023)

Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children
by: Xianhuan Shen, et al.
Published: (2024)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
by: Yahui Zhang, et al.
Published: (2021)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
by: Chang-He Niu, et al.
Published: (2020)

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib
by: Ki-Young Huh, et al.
Published: (2021)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
by: Xingchen Bian, et al.
Published: (2024)

Dosing recommendation of nirmatrelvir/ritonavir using an integrated population pharmacokinetic analysis
by: Phylinda L. S. Chan, et al.
Published: (2023)

Is Dosing of Ethambutol as Part of a Fixed-Dose Combination Product Optimal for Mechanically Ventilated ICU Patients with Tuberculosis? A Population Pharmacokinetic Study
by: Francisco Beraldi-Magalhaes, et al.
Published: (2021)

Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment
by: Ahmed KA, et al.
Published: (2024)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
by: Xuan Gao, et al.
Published: (2021)

Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
by: Zhen-Hai Shang, et al.
Published: (2022)

Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects
by: Ying Zhou, et al.
Published: (2018)

Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization
by: Meng Gu, et al.
Published: (2023)

Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
by: He S, et al.
Published: (2022)

Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
by: Thu-Minh Nguyen, et al.
Published: (2021)

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
by: Ragia H. Ghoneim, et al.
Published: (2021)

Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients
by: Hideo Kato, et al.
Published: (2021)